BCIS SOO - Final 26MAY2026.docx

DOCX document 54 KB Posted

Attached to
Biological Containment Isolation System (BCIS)
Solicitation number
W911QY-26-S-BCIS-01
Issued by

About this file

This is a Statement of Objectives (SOO) for the Biological Containment Isolation System (BCIS) prototype development program, issued by the Joint Project Manager for Chemical, Biological, Radiological, and Nuclear Defense on behalf of the U.S. Army Contracting Command-Aberdeen Proving Ground. The Government seeks innovative solutions to convert the existing USAF TMT60 positive-pressure tent shelter into a modular, field-installable negative-pressure isolation system capable of managing patients with High Consequence Infectious Diseases (HCID) in both Continental United States (CONUS) and overseas locations. The core requirement is a kit that allows medical staff to safely monitor and treat patients while minimizing infection risk to other patients and staff. The acquisition strategy employs a multi-phased prototype approach under Other Transaction Authority (10 U.S.C. 4022), with up to three contractors selected for Phase I, followed by down-selection to two contractors for Phase II, and potential follow-on production of up to 15 units awarded non-competitively to the successful prototype developer.

Phase I requires delivery of three prototypes meeting a minimum Technology Readiness Level (TRL) of 6 within 60-90 days post-award, followed by Government testing and demonstration to assess performance, technical maturity, cost, and risk reduction. Phase II deliverables include five prototypes (three for testing, two for operational demonstration) meeting a minimum TRL of 7, with contractor support for Initial Key Personnel Training and execution of demonstration vignettes. Critical threshold requirements include negative pressure differential of -2.5 Pa (-0.01 in. w.g.), 12 air changes per hour, 99.97% filtration efficiency at 0.3 microns, system reliability greater than 0.95, continuous operation capability for 72 hours, setup time of 30 minutes with four operators, and full reversibility to the original tent configuration. The system must accommodate two single-patient HCID units and four standard litters, secure the floor against mushrooming, include outward-swinging sealed doors operable by a single person in medical PPE, provide directional airflow at diagonally opposite corners, comply with regulatory requirements (CDC, FDA, OSHA, NIOSH, DOT), meet noise, EMI, environmental, and transportation standards, and operate on existing TMT60 power without exceeding a 463L pallet weight limit. The Government's strong preference is Unlimited Rights to all technical data and intellectual property, with proposals offering less than Government Purpose Rights subject to negative evaluation. Data deliverables include a Start of Work meeting, Integrated Master Schedule, safety documentation, operator and maintenance manuals, system support documentation, and evidence of Berry Amendment compliance.

View the file

Other files

File Type Posted
BCIS CFS 10JULY2026 final.docx DOCX document
BCIS SOO 10JULY2026 final.docx DOCX document
Industry Day Questions_30 June 2026.pdf PDF
BCIS CFS - 01July2026 final.docx DOCX document
BCIS CFS - Final 26MAY2026 Rev final.docx DOCX document
BCIS CFS - Final 26MAY2026.docx DOCX document
BCIS SOO Final Rev1 29MAY2026.docx DOCX document
Questions and Asnwers - Updated 17Jun.docx DOCX document
BCIS SOO - Final Rev 1 - 29MAY2026.docx DOCX document
Questions and Asnwers.docx DOCX document
BCIS SOO Final 29MAY2026.pdf PDF
BCIS CFS - Final 26MAY2026.docx DOCX document
BCIS CFS - Final 26MAY2026.docx DOCX document
BCIS SOO - Final 26MAY2026.docx DOCX document
Show all 14

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

STATEMENT OF OBJECTIVE (SOO)

DISTRIBUTION A. Authorized for public release, distribution unlimited.

PROJECT TITLE: Biological Containment Isolation System (BCIS)

BACKGROUND

The Capability Program Executive for Chemical, Biological, Radiological, and Nuclear Defense (CPE CBRND) and Joint Project Manager for CBRN Protection are seeking innovative biological containment, isolation, and quarantine (BIQ) capabilities for managing High-Consequence Infectious Disease (HCID) infected patients during contingency operations, in locations both in the Continental United States (CONUS) and Outside CONUS (OCONUS). The desire is for a modular, field-installable kit that will allow the conversion of the United States Air Force UTS Systems - Tactical Military Tall 60 (TMT60) positive pressure tent shelter to a negative pressure Multi-Patient BCIS tent / shelter. The BCIS will allow medical staff to monitor and/or treat patients while decreasing the risk of infecting other patients and staff.

ACQUISITION STRATEGY & OBJECTIVES

This Statement of Objectives (SOO) defines the goals for a multi-phased prototype project.

3.1 Acquisition Approach

Subject to the availability of funds, the Government intends to make multiple awards for prototype solutions. Up to three (3) contractors will be selected for Phase I. Following Phase I, the Government will conduct a down-selection to determine which contractors (up to two) will proceed to Phase II. An award to participate in Phase I is a prerequisite for consideration for Phase II.

To be considered successful and eligible for a non-competitive follow-on production award after Phase II, a prototype must meet the following criteria. The Government reserves the right to update or refine evaluation criteria prior to Phase II award to ensure alignment with program objectives and operational needs, provided such updates do not alter the requirements specified in Attachment 1.

Table 1: Successful prototype criteria.

Requirement
Threshold
Force Protection
Negative pressure differential of 0.01 In.w.g

≥12 Air Changes per Hour (ACH)

99.97% at 0.3-micron particle diameter

System Interruption
Visual alarm when pressure is outside the required negative pressure range
Patient Access
Anteroom allows personnel and a litter-bound patient ingress/egress while maintaining negative pressure
Modularity & Reversibility
The TMT60 tent must be fully returnable to its original configuration. Modifications must either be fully removable without damage or, if left in place, must not interfere with the tent's original form, fit, or function.
Directional Airflow
Clean air inlet and filtered air exhaust should be positioned to maximize airflow, optimally at diagonally opposite corners in rectangular tents.
Floor
The kit must secure the floor against the ground to prevent "mushrooming" and maintain tautness and trip-free conditions under negative pressure.
Walls
Supplementary structural components must be included to prevent inward collapse and minimize deflection of tent walls, integrating with the existing frame.
Doors
Entry/exit doors must be modified or replaced to be outward-swinging, form a tight seal, resist deformation from negative pressure, and have a robust latch operable by a single person wearing medical PPE from both sides.
Patient Movement
System accommodates movement of patients on standard litters (94” x 31”) while maintaining negative pressure
Power
Connects to and operates on power from existing TMT60 tent

The solution must operate at normal temperature IAW MIL-STD 810H and pressure (between 0.69 atm - 1 atm)

Reusability
System can be safely decontaminated and reused
Noise Level
The noise generated by the solution shall not exceed the levels of the equipment (e.g, generator, air filtration system, environmental control solution) used with the TMT60 shelter
Shelf Life
5 years (filters) / 10 years (non-filters)
Environmental
No operational degradation from wind, rain, sand, or dust
EMI
Meets applicable MIL-STD-461 and MIL-STD-464
Transportation
Must demonstrate ability to be transported in stored configuration
Occupancy
Isolation room to accommodate two single-patient HCID units (118 in L X 54 in W X 76 in H) and four litters (94 in L X 31 in W).
Regulatory Compliance
System must meet all regulatory compliance requirements (e.g. CDC, FDA, OSHA, NIOSH, DOT) for safe operation and to minimize risk of exposure to other personnel, as required.

3.2 Follow-on Production Authority

Upon successful completion of a prototype Other Transaction Authority (OTA) competitively awarded from this SOO, the Government may issue a follow-on production contract for up to 15 units without further competition, in accordance with 10 U.S.C. § 4022.

3.3 Proposal Requirements

Offerors shall use this SOO as the basis for preparing a draft Statement of Work (SOW), which will be included as an integral part of the proposal. The proposal shall address the objectives of each phase for a multi-patient solution and include a draft Statement of Work (SOW) for the Government's consideration. Multiple SOW submissions per Offeror are acceptable.

This project is unclassified.

The proposal must contain the following distinct elements:

· A detailed master delivery schedule for all prototypes and data deliverables.

· The total firm-fixed-price for all prototypes and associated deliverables in each Phase.

· The Offeror's projected unit cost for a potential Full Rate Production (FRP) quantity.

· The Offeror's demonstrated or projected maximum monthly production rate.

· Supporting documentation to substantiate performance claims, including but not limited to: Technology Readiness Level (TRL) data, production lead times, test plans and reports, High Consequence Infectious Disease (HCID) containment data, analysis of interoperability with existing military field hospitals, power requirements, and durability data.

3.4 Phased Objectives

The following objectives apply to each phase. All requirements from Phase I carry forward and apply to Phase II, in addition to the new objectives listed for Phase II.

Phase I (Three Prototypes)

· Objective 1 (Delivery): The Contractor shall deliver three (3) prototypes meeting a minimum TRL of six (6) to a Government-specified CONUS location for Phase I testing.

· Objective 2 (Demonstration): At the specified location, the Contractor shall conduct a system demonstration of the prototype, covering setup, operational use (including containment), and breakdown procedures.

· Objective 3 (Evaluation): During the demonstration, Government and user personnel will conduct an assessment against the requirements. The Government will perform on-site confirmation of containment capabilities using Government-owned equipment. Upon completion of demonstration activities, the Government will transport the prototype to a designated facility for additional Government laboratory testing.

The Government will evaluate Phase I prototypes to determine which candidates will continue to Phase II, based on the following factors, listed in descending order of importance:

1. Performance The extent to which the prototype meets or exceeds the requirements and test objectives outlined in Tables 2 and 3, Phase I Criteria, as demonstrated by Government test results, data, and analysis.

2. Technical Maturity The readiness level of the prototype, including prior laboratory or operational testing with the Government’s validation, TRL, and supporting documentation that demonstrates the system’s ability to meet the KPP threshold requirements in Attachment 1.

3. Item Cost The proposed price for the prototype system including supporting cost breakdowns.

4. Risk Reduction Submitted Risk Management Plan and associated risk register; results from component/subsystem qualification testing; material selection reports.

Phase II (Five Prototypes)

· Objective 4 (Delivery for Testing): The Contractor shall deliver three (3) prototypes meeting a minimum TRL of seven (7) to a Government-specified CONUS test facility for Phase II testing.

· Objective 5 (Delivery for Demonstration): The Contractor shall deliver two (2) prototypes to a Government-specified CONUS location for operational and logistics demonstrations.

· Objective 6 (Training and Support): The Contractor shall support an Initial Key Personnel Training (IKPT) event. Following this training, Government personnel will execute all operational and logistics demonstration vignettes using the Contractor-provided manuals. Upon completion of all Phase II activities, the Contractor shall transport the prototypes from the Government facilities.

Final Prototype Selection Criteria:

The evaluation factors for the final selection (following completion of Phase II testing) will include, at a minimum:

1. Performance Results of all testing conducted in Phases I and II, as measured against the requirements in Attachment 1.

2. User Feedback Usability and human systems integration, as assessed during operational evaluation and user touchpoints.

3. Affordability Overall cost, including production cost, life-cycle cost, and sustainment.

The relative order of importance for these factors will be provided prior to Phase II award. At this time, performance is anticipated to be the most important factor, followed by user feedback, then affordability. The Government reserves the right to update or refine evaluation criteria prior to Phase II award to ensure alignment with program objectives and operational needs, provided such updates do not alter the requirements specified in Attachment 1. The Government reserves the right to award one (1) or more production follow on contracts or transactions.

SYSTEM (HARDWARE) DELIVERABLES

Specific delivery dates will be negotiated into the final SOW.

· Phase I: Three (3) prototype TMT60 negative-pressure conversion kits meeting a minimum TRL of 6 (Prototype demonstration in a relevant environment). (Delivery 60-90 days post-award).

· Phase II: Five (5) prototype TMT60 negative-pressure conversion kits meeting a minimum TRL of 7 (Prototype demonstration in an operational environment). (Delivery 60-90 days post-Phase II start).

DATA DELIVERABLES

The Contractor shall deliver all data in formats to be negotiated and agreed upon with the Authorized Organizational Representative (AOR).

4.1 Start of Work Meeting & Minutes: Within 30 days of award, the Contractor shall host a Start of Work meeting to establish the project baseline, schedule, and risks. The Contractor shall deliver meeting minutes.

4.2 Test Support: The Contractor shall provide on-site technical support for test events as required. Assume two (2) travel days and two (2) days of support for each phase.

4.3 Schedule: The Contractor shall create, maintain, and execute against an Integrated Master Schedule (IMS).

4.4 Technical Data & Intellectual Property: The Government requires sufficient data rights to operate, maintain, and sustain the BCIS for its entire lifecycle.

Government Preference: The Government’s strong preference is for Unlimited Rights for all technical data, software, and associated intellectual property developed under this effort.

Offeror Assertions: The Offeror must include a table detailing any data rights assertions for technical data or software being provided with less than an unlimited/unrestricted license. This includes both commercial and non-commercial items. The Offeror must explain how this approach provides the best value to the Government over the system's lifecycle.

Evaluation Impact: The Government will evaluate the impact of any proposed data rights restrictions. Proposals that provide less than Government Purpose Rights (GPR) for the prototype design, or which hinder the competitive procurement of future sustainment services, may be evaluated negatively and could be a deciding factor in the selection decision.

4.5 Berry Amendment Compliance: The Contractor shall provide documentation verifying compliance with the Berry Amendment and detail the sourcing of any non-compliant items.

4.6 Safety Documentation: The Contractor shall deliver a Safety Assessment Report (SAR), Safety Data Sheets, and all necessary documentation for safe storage and disposal. At a minimum, the SAR shall summarize safety and health hazard data, provide a comprehensive evaluation of the safety and health risks, and identify procedures/precautions required for safe use of the system/subsystem and systems.

4.7 Manuals: The Contractor shall deliver all commercial or newly developed operator and maintenance manuals, updating them as the system baseline changes.

4.8 System Support Documentation: The Contractor shall deliver documentation specifying system size, weight, materials, equipment list, modes of operation, operating limits, and storage/transportation constraints.

PERIOD AND PLACE OF PERFORMANCE

The Contractor shall propose a delivery schedule in its SOW to include test support, technical readiness assessments, and other deliverables as outlined in Section 4.0. Prototype development will occur at the Contractor’s facility. Demonstrations and testing will occur at CONUS Government facilities designated after award.

AGREEMENTS OFFICER REPRESENTATIVE (AOR)

All communications and inquiries regarding this CFS shall be directed exclusively to the Agreements Officer.

· Agreements Officer: Dan L. Adams, Jr.

· Email: dan.l.adams2.civ@army.mil

ATTACHMENT 1 – PERFORMANCE REQUIREMENTS

The proposed solution should meet the Threshold requirements outlined in Table 2. Solutions exceeding Thresholds to meet Objective requirements are desired. The criteria in Table 3 will be used as additional considerations in the Government's best-value determination.

Table 2: Evaluation Criteria

Functional Area
Threshold
Objective
Verification Method
Phase
Negative Pressure
-2.5 Pa (≈ -0.01 in. w.g.) differential
-7.5 Pa (≈ -0.03 in. w.g.) differential
Government Test (GT) / Demonstration
I and II
Air Exchange Rate
≥12 Air Changes per Hour (ACH)
≥25 ACH
Calculation based on enclosure volume and system airflow; confirmed via GT
I and II
Filtration Efficiency
99.97% removal of 0.3-micron particles
99.997% removal of 0.3-micron particles
GT in accordance with DOE-STD-3025-2022
I and II
Modularity and Reversibility
The tent must be fully returnable to its original configuration. Modifications must either be fully removable without damage or, if left in place, must not interfere with the tent's original form, fit, or function.
Government Test (GT) / Demonstration
I and II
Regulatory Compliance
System must meet all regulatory compliance requirements (e.g. CDC, FDA, OSHA, NIOSH, DOT) for safe operation and to minimize risk of exposure to other personnel, as required.
Inspection
II
Directional Airflow
To ensure effective air exchange and prevent short-circuiting, the clean air inlet and the filtered air exhaust should be positioned to maximize the air path through the tent's operational volume. In a rectangular tent, optimally the inlet and exhaust would be diagonally on opposite corners of the structure.
Government Test (GT) / Demonstration
I and II
Floor
The conversion kit shall include a method to secure the floor against the ground, preventing vertical displacement ("mushrooming") without compromising the floor’s integrity. This system must be effective up to the maximum specified negative pressure. The floor shall remain taut and free of trip hazards
Government Test (GT) / Demonstration
I
Walls
The kit shall include supplementary structural components to prevent the inward collapse and minimize deflection of the tent walls. These components must integrate with the existing tent frame at specified intervals to maintain the original design footprint and internal volume of the tent under operational negative pressure.
Government Test (GT) / Demonstration
I
Doors
· Door Configuration: All designated entry/exit doors shall be modified or replaced to be outward-swinging and form a tight seal when closed.

· Seal Integrity: The door and frame must be rigid enough to resist deformation from the negative pressure.

· Latching Mechanism: The latching mechanism must be operable by a single person wearing medical PPE from both the interior and exterior. The mechanism must be robust enough to hold the door securely closed against the negative pressure.

Government Test (GT) / Demonstration
I
Duration of use
The system shall be capable of continuous use for 72-hours
96 hours
Government Test (GT) / Demonstration
I and II
System Interruption
Visual alarm when pressure is outside the required negative range
Visual and audible alarms
Demonstration
I
Patient Access
Anteroom allows personnel and a litter-bound patient ingress/egress while maintaining negative pressure
Demonstration
I
Patient Movement
System accommodates movement of patients on standard litters (94” x 31”) while maintaining negative pressure
Demonstration
I
Power
Connects to and operates on power from existing TMT60 tent shelter
Demonstration
I
The solution must operate at normal temperature IAW MIL-STD 810H and pressure (between 0.69 atm - 1 atm)
Demonstration
I
Reusability
System can be safely decontaminated and reused
Vendor Data / GT
I
Percentage Reliability
System will have reliability for continuous operations of greater than or equal to 0.95
Greater than or equal to 0.99
GT / Demonstration
II
Operational Mission Failure
Without an Operational Mission Failure, the system shall be able to reliably operate continuously for 72 hours
96 hours
GT / Demonstration
I and II
Maintainability
For all field level corrective maintenance actions, Mean Corrective Maintenance Time (MCMT) for the system must not exceed 30 minutes
15 minutes
GT / Demonstration
I and II
Noise Level
The noise generated by the solution shall not exceed the levels of the equipment (e.g, generator, air filtration system, environmental control solution) used with the TMT60 shelter
GT in accordance with MIL-STD-1474
I and II
Setup time
30 minutes
20 minutes
Government Test (GT) / Demonstration
I
Number of personnel to convert tent to negative pressure
Four operators to convert the existing tents to a HCID tent with negative pressure
Two operators
Government Test (GT) / Demonstration
I
Shelf Life, Non-Filters
10 years
10 years
Vendor Data / Analysis based on ASTM F1980
II
Shelf Life, Filters
5 years
> 5 years
Vendor Data / Analysis based on ASTM F1980
II
Environmental
No operational degradation from wind, rain, sand, or dust
GT in accordance with specified MIL-STD-810 methods
II
Altitude
Operate safely at low pressure
Leverage data/GT IAW MIL-STD-810/Demonstration
I and II
EMI
Meets applicable MIL-STD-461 and MIL-STD-464
GT / Certified Test Report
II
Transportation
Must demonstrate ability to be transported in stored configuration
Demonstration
I
Occupancy
Isolation room to accommodate two single-patient HCID units (118 in L X 54 in W X 76 in H) and four litters (94 in L X 31 in W).
Demonstration
I
System Weight
Not to exceed weight limit of 463L pallet
Demonstration
I
Packaging
Not to exceed usable space on a 463L pallet
Demonstration
I
Storage
System can be stored in environmentally controlled facilities
Will not require climate controls
Vendor Data / Analysis
II

Table 3: Additional Criteria

Factor
Evaluation Method
Procurement Cost
Lower evaluated price for prototypes is more favorable.
Sustainment Cost
Lower projected lifecycle cost is more favorable.
Producibility
Higher demonstrated production rate is more favorable.
Human Systems Integration (HSI)
Favorable qualitative feedback and quantitative ratings from users.

File details come from the government source that posted it. Updated .